The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Hermann E. Wasmuth

Medical Department III

University Hospital Aachen

RWTH Aachen



Name/email consistency: high



  • Medical Department III, University Hospital Aachen, RWTH Aachen, Germany. 2004 - 2010


  1. Chemokines in liver inflammation and fibrosis. Wasmuth, H.E., Tacke, F., Trautwein, C. Semin. Liver Dis. (2010) [Pubmed]
  2. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Wasmuth, H.E., Lammert, F., Zaldivar, M.M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M.L., Zimmermann, H., Streetz, K.L., Tacke, F., Hillebrandt, S., Schmitz, P., Keppeler, H., Berg, T., Dahl, E., Gassler, N., Friedman, S.L., Trautwein, C. Gastroenterology (2009) [Pubmed]
  3. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. Wasmuth, H.E., Zaldivar, M.M., Berres, M.L., Werth, A., Scholten, D., Hillebrandt, S., Tacke, F., Schmitz, P., Dahl, E., Wiederholt, T., Hellerbrand, C., Berg, T., Weiskirchen, R., Trautwein, C., Lammert, F. J. Hepatol. (2008) [Pubmed]
  4. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. Wasmuth, H.E., Werth, A., Mueller, T., Berg, T., Dietrich, C.G., Geier, A., Schirin-Sokhan, R., Gartung, C., Lorenzen, J., Matern, S., Lammert, F. J. Mol. Med. (2004) [Pubmed]
  5. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. Wasmuth, H.E., Stolte, C., Geier, A., Dietrich, C.G., Gartung, C., Lorenzen, J., Matern, S., Lammert, F. BMC Infect. Dis. (2004) [Pubmed]
WikiGenes - Universities